Janus Henderson Group PLC boosted its position in Monsanto Company (NYSE:MON) by 57.1% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 2,342,693 shares of the basic materials company’s stock after buying an additional 851,369 shares during the period. Janus Henderson Group PLC owned approximately 0.53% of Monsanto worth $280,696,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other hedge funds and other institutional investors have also recently modified their holdings of the stock. Vanguard Group Inc. boosted its position in Monsanto by 2.6% in the second quarter. Vanguard Group Inc. now owns 30,725,725 shares of the basic materials company’s stock valued at $3,636,697,000 after buying an additional 784,418 shares during the last quarter. BlackRock Inc. lifted its holdings in Monsanto by 6.5% in the second quarter. BlackRock Inc. now owns 27,898,255 shares of the basic materials company’s stock valued at $3,302,038,000 after acquiring an additional 1,705,439 shares during the period. State Street Corp lifted its holdings in Monsanto by 0.6% in the second quarter. State Street Corp now owns 20,276,780 shares of the basic materials company’s stock valued at $2,399,965,000 after acquiring an additional 122,814 shares during the period. Northern Trust Corp lifted its holdings in Monsanto by 0.7% in the second quarter. Northern Trust Corp now owns 7,092,929 shares of the basic materials company’s stock valued at $839,519,000 after acquiring an additional 47,725 shares during the period. Finally, Flossbach Von Storch AG lifted its holdings in Monsanto by 7.5% in the second quarter. Flossbach Von Storch AG now owns 4,397,000 shares of the basic materials company’s stock valued at $520,429,000 after acquiring an additional 307,600 shares during the period. Hedge funds and other institutional investors own 75.70% of the company’s stock.
In related news, VP Duraiswami Narain sold 2,860 shares of the stock in a transaction on Monday, September 25th. The stock was sold at an average price of $120.00, for a total value of $343,200.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Steven Mizell sold 11,526 shares of the stock in a transaction on Monday, October 9th. The shares were sold at an average price of $119.70, for a total value of $1,379,662.20. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 49,236 shares of company stock valued at $5,931,934. Corporate insiders own 0.79% of the company’s stock.
Monsanto Company (NYSE MON) opened at $117.30 on Friday. The company has a debt-to-equity ratio of 1.12, a quick ratio of 0.83 and a current ratio of 1.35. The firm has a market capitalization of $51,635.46, a P/E ratio of 21.21, a PEG ratio of 1.69 and a beta of 1.04. Monsanto Company has a 52 week low of $104.08 and a 52 week high of $122.79.
Monsanto (NYSE:MON) last announced its earnings results on Wednesday, October 4th. The basic materials company reported $0.20 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.41) by $0.61. The business had revenue of $2.69 billion during the quarter, compared to the consensus estimate of $2.51 billion. Monsanto had a return on equity of 42.40% and a net margin of 15.44%. The business’s quarterly revenue was up 4.8% on a year-over-year basis. During the same period in the prior year, the company posted $0.07 EPS. research analysts anticipate that Monsanto Company will post 5.74 earnings per share for the current year.
The firm also recently announced a quarterly dividend, which will be paid on Friday, January 26th. Stockholders of record on Friday, January 5th will be paid a dividend of $0.54 per share. This represents a $2.16 annualized dividend and a dividend yield of 1.84%. The ex-dividend date of this dividend is Thursday, January 4th. Monsanto’s payout ratio is 42.27%.
A number of research analysts have issued reports on the company. UBS downgraded Monsanto from a “buy” rating to a “neutral” rating and set a $128.00 price target for the company. in a report on Friday, August 18th. Zacks Investment Research downgraded Monsanto from a “buy” rating to a “hold” rating in a report on Wednesday, August 30th. Wells Fargo & Company boosted their price target on Monsanto from $107.50 to $118.00 and gave the company a “market perform” rating in a report on Tuesday, October 10th. Royal Bank Of Canada reissued a “hold” rating and issued a $128.00 price target on shares of Monsanto in a report on Wednesday, November 15th. Finally, Macquarie downgraded Monsanto from an “outperform” rating to a “neutral” rating in a report on Wednesday, October 4th. Eleven research analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. The stock presently has an average rating of “Hold” and a consensus target price of $124.61.
COPYRIGHT VIOLATION WARNING: “Janus Henderson Group PLC Purchases 851,369 Shares of Monsanto Company (MON)” was first posted by The Ledger Gazette and is the property of of The Ledger Gazette. If you are accessing this story on another publication, it was illegally copied and reposted in violation of US and international trademark & copyright law. The legal version of this story can be read at https://ledgergazette.com/2017/12/10/janus-henderson-group-plc-purchases-851369-shares-of-monsanto-company-mon.html.
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
Want to see what other hedge funds are holding MON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Monsanto Company (NYSE:MON).
Receive News & Ratings for Monsanto Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Company and related companies with MarketBeat.com's FREE daily email newsletter.